Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…
Biotechnology
US, Berwyn [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Annovis Bio, Inc. (ANVS) to it's peer group.
Peer Group
AXSM AVXL LTRN IMNM CUE DAWN TFFP GRTX INAB RVPH TERN SAVA INZY ANIX NVAX ABOS MCRB IOVA
Compare Together
Loading...